English Polski
Vol 28, No 1 (2022)
Research paper
Published online: 2022-05-02

open access

Page views 4913
Article views/downloads 396
Get Citation

Connect on Social Media

Connect on Social Media

Evaluation of the Predictive Role of Standard Laboratory Tests for Disease Severity in Patients with Deep Venous Thrombosis

Mustafa Etli1, Oguz Karahan1, Faruk Serhatlıoglu2, Hakan Ontas3
Acta Angiologica 2022;28(1):16-21.


Introduction: Deep venous thrombosis (DVT) can result in fatal outcomes if it is not timely diagnosed and sufficiently treated. Some laboratory markers were identified in previous reports for predicting the disease with low sensitivity or specificity. We aimed to evaluate the predictive value of serum albumin levels and compare them with conventional laboratory parameters. Material and Methods: Fifty patients with acute lower-extremity DVT who has no previous history of malignancy or hematologic disorder were included in the study. The demographical variables and standard biomarkers of the DVT group were compared with the normal population (n:50). Thereafter patients were divided into two groups as extensive DVT (thrombosis involves popliteal, femoral, and iliac veins together) and localized DVT (thrombosis involves popliteal vein and below) and biomarkers were compared in patient groups. Results: The demographical variables and white blood cell count (WBC) found as similar between healthy groups and DVT groups. However, mean platelet volume (MPV), D-Dimer, neutrophil to lymphocyte ratio (NLR), and fibrinogen to albumin ratio (FAR) were found markedly higher in DVT patients. Moreover, statistically incremental FAR and NLR levels were detected (p < 0.05) in patients with extensive DVT (involved iliac and femoral veins). Conclusion: Serum NLR and FAR levels seem to be significant predictors for the extensive thrombotic event in patients with DVT.

Article available in PDF format

View PDF Download PDF file


  1. Thachil J. Deep vein thrombosis. Hematology. 2014; 19(5): 309–310.
  2. Baglin T. Using the laboratory to predict recurrent venous thrombosis. Int J Lab Hematol. 2011; 33(4): 333–342.
  3. Riddle DL, Hillner BE, Wells PS, et al. Diagnosis of lower-extremity deep vein thrombosis in outpatients with musculoskeletal disorders: a national survey study of physical therapists. Phys Ther. 2004; 84(8): 717–728.
  4. Rabinovich A, Cohen JM, Cushman M, et al. Inflammation markers and their trajectories after deep vein thrombosis in relation to risk of post-thrombotic syndrome. J Thromb Haemost. 2015; 13(3): 398–408.
  5. Aydın U. Is low serum albumin level a risk factor for deep venous thrombosis in temporary hemodialysis catheter inserted patients? Turkish Journal of Thoracic and Cardiovascular Surgery. 2013; 21(4): 955–958.
  6. Rezende SM, Lijfering WM, Rosendaal FR, et al. Hematologic variables and venous thrombosis: red cell distribution width and blood monocyte count are associated with an increased risk. Haematologica. 2014; 99(1): 194–200.
  7. Byrnes JR, Wolberg AS, Walton BL, et al. Fibrinogen and red blood cells in venous thrombosis. Thromb Res. 2014; 133 Suppl 1(16): S38–S40.
  8. Wakefield TW, Strieter RW, Schaub R. Venous thrombosis prophylaxis by inflammatory inhibition without anticoagulation therapy. J Vasc Surg. 2000; 31(2): 309–324.
  9. Gulcan M, Varol E, Etli M, et al. Mean platelet volume is increased in patients with deep vein thrombosis. Clin Appl Thromb Hemost. 2012; 18(4): 427–430.
  10. Lai HM, Xu R, Yang YN, et al. Association of mean platelet volume with angiographic thrombus burden and short-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Catheter Cardiovasc Interv. 2015; 85 Suppl 1: 724–733.
  11. Tanboga IH, Topcu S, Aksakal E, et al. Determinants of angiographic thrombus burden in patients with ST-segment elevation myocardial infarction. Clin Appl Thromb Hemost. 2014; 20(7): 716–722.
  12. Erkol A, Oduncu V, Turan B, et al. Neutrophil to lymphocyte ratio in acute ST-segment elevation myocardial infarction. Am J Med Sci. 2014; 348(1): 37–42.
  13. Barker T, Rogers VE, Henriksen VT, et al. Is there a link between the neutrophil-to-lymphocyte ratio and venous thromboembolic events after knee arthroplasty? A pilot study. J Orthop Traumatol. 2016; 17(2): 163–168.
  14. Canan A, Halıcioğlu SS, Gürel S. Mean platelet volume and D-dimer in patients with suspected deep venous thrombosis. J Thromb Thrombolysis. 2012; 34(2): 283–287.
  15. Klovaite J, Nordestgaard BG, Tybjærg-Hansen A, et al. Elevated fibrinogen levels are associated with risk of pulmonary embolism, but not with deep venous thrombosis. Am J Respir Crit Care Med. 2013; 187(3): 286–293.
  16. Joven J, Clivillé X, Camps J, et al. Plasma protein abnormalities in nephrotic syndrome: effect on plasma colloid osmotic pressure and viscosity. Clin Chem. 1997; 43(7): 1223–1231.
  17. Folsom AR, Lutsey PL, Heckbert SR, et al. Serum albumin and risk of venous thromboembolism. Thromb Haemost. 2010; 104(1): 100–104.
  18. Sapmaz I, Saba T, Haberal C, et al. Fibrinogen- Albumin Ratio: An Intriguing Relationship for Assessing Trombosis Risk and Suspicious Effect on Blood viscosity. International Cardiovascular Research Journal. 2011; 5(4): 153–154.
  19. Karahan O, Yavuz C, Kankilic N, et al. Simple blood tests as predictive markers of disease severity and clinical condition in patients with venous insufficiency. Blood Coagul Fibrinolysis. 2016; 27(6): 684–690.